NRF2 regulates HER1 signaling pathway to modulate the sensitivity of ovarian cancer cells to lapatinib and erlotinib

Ibrahim Hamza Kankia, Hilal S. Khalil, Simon P. Langdon, Peter R. Moult, James L. Bown, Yusuf Y. Deeni^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

20 Citations (Scopus)

98 Downloads (Pure)

1 results
- Title(descending)
- Award date

Design and development of novel tools for the screening and identification of inhibitors of HER receptor family and NFR2 for ovarian cancer therapy
Author: Hamza Kankia, I., 31 Oct 2017
Supervisor: Moult, P. R. (Supervisor) & Deeni, Y. Y. (Supervisor)
Student thesis: Doctoral Thesis

File